A detailed history of Cynosure Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Cynosure Management, LLC holds 2,630 shares of ABBV stock, worth $465,378. This represents 0.08% of its overall portfolio holdings.

Number of Shares
2,630
Previous 2,236 17.62%
Holding current value
$465,378
Previous $383,000 35.51%
% of portfolio
0.08%
Previous 0.06%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$163.84 - $199.33 $64,552 - $78,536
394 Added 17.62%
2,630 $519,000
Q2 2024

Aug 13, 2024

BUY
$154.79 - $180.76 $55,260 - $64,531
357 Added 19.0%
2,236 $383,000
Q1 2024

May 10, 2024

BUY
$159.82 - $182.1 $300,301 - $342,165
1,879 New
1,879 $342,000
Q2 2023

Aug 14, 2023

BUY
$132.51 - $164.9 $703,230 - $875,124
5,307 New
5,307 $715,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $313B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Cynosure Management, LLC Portfolio

Follow Cynosure Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cynosure Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cynosure Management, LLC with notifications on news.